Xencor, Inc Share-based Payment Arrangement, Expense
Xencor, Inc (XNCR) reported Share-based Payment Arrangement, Expense of $53.30 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-02-27
- Xencor, Inc share-based payment arrangement, expense for the quarter ending 2020-12-31 was $8.54M, a 18.15% increase year-over-year.
- Xencor, Inc share-based payment arrangement, expense for the quarter ending 2020-09-30 was $8.32M, a 12.57% decline year-over-year.
- Xencor, Inc share-based payment arrangement, expense for the quarter ending 2020-06-30 was $8.23M, a 11.52% decline year-over-year.
- Xencor, Inc share-based payment arrangement, expense for the quarter ending 2020-03-31 was $6.51M, a 11.20% increase year-over-year.
- Xencor, Inc share-based payment arrangement, expense for fiscal 2024 was $53.30M, a 0.93% decline from fiscal 2023.
- Xencor, Inc share-based payment arrangement, expense for fiscal 2023 was $53.80M, a 10.02% increase from fiscal 2022.
- Xencor, Inc share-based payment arrangement, expense for fiscal 2022 was $48.90M, a 32.16% increase from fiscal 2021.
- Xencor, Inc share-based payment arrangement, expense for fiscal 2021 was $37.00M, a 17.09% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $53.30M 10-K · filed 2025-02-27 | ||||
| 2023-12-31 | $53.80M 10-K · filed 2025-02-27 | ||||
| 2022-12-31 | $48.90M 10-K · filed 2025-02-27 | ||||
| 2021-12-31 | $37.00M 10-K/A · filed 2025-02-24 | ||||
| 2020-12-31 | $8.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $16.86M derived: sum of 2 quarters · filed 2023-02-27 | $25.09M derived: sum of 3 quarters · filed 2023-02-27 | $31.60M 10-K · filed 2023-02-27 | $31.62M 10-K · filed 2021-02-24 |
| 2020-09-30 | $8.32M 10-Q · filed 2020-11-06 | $16.55M derived: sum of 2 quarters · filed 2020-11-06 | $23.06M 10-Q · filed 2020-11-06 | $30.29M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $8.23M 10-Q · filed 2020-08-05 | $14.74M 10-Q · filed 2020-08-05 | $21.97M derived: sum of 3 quarters · filed 2022-02-24 | $31.48M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $6.51M 10-Q · filed 2020-05-08 | $13.74M derived: sum of 2 quarters · filed 2022-02-24 | $23.25M derived: sum of 3 quarters · filed 2022-02-24 | $32.56M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $7.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $16.74M derived: sum of 2 quarters · filed 2022-02-24 | $26.04M derived: sum of 3 quarters · filed 2022-02-24 | $31.90M 10-K · filed 2022-02-24 | $31.85M 10-K · filed 2020-02-25 |
| 2019-09-30 | $9.51M 10-Q · filed 2020-11-06 | $18.82M derived: sum of 2 quarters · filed 2020-11-06 | $24.67M 10-Q · filed 2020-11-06 | $29.75M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $9.30M 10-Q · filed 2020-08-05 | $15.16M 10-Q · filed 2020-08-05 | $20.23M derived: sum of 3 quarters · filed 2021-02-24 | $26.35M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $5.86M 10-Q · filed 2020-05-08 | $10.93M derived: sum of 2 quarters · filed 2021-02-24 | $17.05M derived: sum of 3 quarters · filed 2021-02-24 | $21.93M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $11.20M derived: sum of 2 quarters · filed 2021-02-24 | $16.08M derived: sum of 3 quarters · filed 2021-02-24 | $20.55M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $6.12M 10-Q · filed 2019-11-05 | $11.00M derived: sum of 2 quarters · filed 2019-11-05 | $15.47M 10-Q · filed 2019-11-05 | $18.91M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $4.88M 10-Q · filed 2019-08-07 | $9.35M 10-Q · filed 2019-08-07 | $12.79M derived: sum of 3 quarters · filed 2020-02-25 | $16.40M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $4.47M 10-Q · filed 2019-05-09 | $7.91M derived: sum of 2 quarters · filed 2020-02-25 | $11.52M derived: sum of 3 quarters · filed 2020-02-25 | $14.96M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $7.04M derived: sum of 2 quarters · filed 2020-02-25 | $10.49M derived: sum of 3 quarters · filed 2020-02-25 | $13.65M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $3.60M 10-Q · filed 2018-11-05 | $7.05M derived: sum of 2 quarters · filed 2018-11-05 | $10.21M 10-Q · filed 2018-11-05 | $12.20M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | $3.45M 10-Q · filed 2018-08-07 | $6.61M 10-Q · filed 2018-08-07 | $8.60M derived: sum of 3 quarters · filed 2019-02-26 | $10.46M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | $3.16M 10-Q · filed 2018-05-07 | $5.15M derived: sum of 2 quarters · filed 2019-02-26 | $7.01M derived: sum of 3 quarters · filed 2019-02-26 | $9.05M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.86M derived: sum of 2 quarters · filed 2019-02-26 | $5.89M derived: sum of 3 quarters · filed 2019-02-26 | $7.85M 10-K · filed 2019-02-26 | |
| 2016-09-30 | $1.87M 10-Q · filed 2017-11-08 | $3.90M derived: sum of 2 quarters · filed 2017-11-08 | $5.86M 10-Q · filed 2017-11-08 | $7.34M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $2.03M 10-Q · filed 2017-08-07 | $3.99M 10-Q · filed 2017-08-07 | $5.48M derived: sum of 3 quarters · filed 2018-02-28 | $6.56M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $1.96M 10-Q · filed 2017-05-10 | $3.44M derived: sum of 2 quarters · filed 2018-02-28 | $4.53M derived: sum of 3 quarters · filed 2018-02-28 | $5.72M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.57M derived: sum of 2 quarters · filed 2018-02-28 | $3.76M derived: sum of 3 quarters · filed 2018-02-28 | $4.87M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $1.09M 10-Q · filed 2016-11-02 | $2.28M derived: sum of 2 quarters · filed 2016-11-02 | $3.39M 10-Q · filed 2016-11-02 | $4.14M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $1.19M 10-Q · filed 2016-08-03 | $2.30M 10-Q · filed 2016-08-03 | $3.05M derived: sum of 3 quarters · filed 2017-03-01 | $3.54M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $1.11M 10-Q · filed 2016-05-02 | $1.86M derived: sum of 2 quarters · filed 2017-03-01 | $2.35M derived: sum of 3 quarters · filed 2017-03-01 | $2.71M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $751.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.24M derived: sum of 2 quarters · filed 2017-03-01 | $1.60M derived: sum of 3 quarters · filed 2017-03-01 | $1.86M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $491.00K 10-Q · filed 2015-11-04 | $852.00K derived: sum of 2 quarters · filed 2015-11-04 | $1.11M 10-Q · filed 2015-11-04 | $1.27M derived: sum of 4 quarters · filed 2016-03-08 | |
| 2014-06-30 | $361.00K 10-Q · filed 2015-08-05 | $639.00K 10-Q · filed 2015-08-05 | $783.00K derived: sum of 3 quarters · filed 2016-03-08 | $827.00K derived: sum of 4 quarters · filed 2016-03-08 | |
| 2014-03-31 | $278.00K 10-Q · filed 2015-05-05 | $422.00K derived: sum of 2 quarters · filed 2016-03-08 | $466.00K derived: sum of 3 quarters · filed 2016-03-08 | $471.00K derived: sum of 4 quarters · filed 2016-03-08 | |
| 2013-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $188.00K derived: sum of 2 quarters · filed 2016-03-08 | $193.00K derived: sum of 3 quarters · filed 2016-03-08 | $198.00K 10-K · filed 2016-03-08 | |
| 2013-09-30 | $44.00K 10-Q · filed 2014-11-10 | $49.00K derived: sum of 2 quarters · filed 2014-11-10 | $54.00K 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $5.00K 10-Q · filed 2014-08-01 | $10.00K 10-Q · filed 2014-08-01 | |||
| 2013-03-31 | $5.00K 10-Q · filed 2014-05-15 | ||||
| 2012-12-31 | $29.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |